Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,41%
1.076,13
-15,38
-1,41%
—1.091,511.090,401.090,401.073,69——
SIXC
Communications
SIXC
Communications
SIXC
-0,55%
606,74
-3,37
-0,55%
—610,11610,11610,29606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,88%
1.248,82
+10,84
+0,88%
—1.237,981.237,831.252,411.225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1.724,36
-20,35
-1,17%
—1.744,711.740,951.747,291.721,57——
SIXM
Financials
SIXM
Financials
SIXM
-0,72%
635,59
-4,59
-0,72%
—640,18639,92643,19634,73——
SIXR
Staples
SIXR
Staples
SIXR
-0,76%
843,15
-6,43
-0,76%
—849,58845,27851,68839,47——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,55%
216,29
-1,19
-0,55%
—217,48217,48218,16215,51——
SIXT
Technology
SIXT
Technology
SIXT
+0,08%
3.263,41
+2,72
+0,08%
—3.260,693.273,363.287,813.240,78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,34%
939,24
-3,21
-0,34%
—942,45939,39948,80933,98——
SIXV
Health care
SIXV
Health care
SIXV
-0,29%
1.462,56
-4,24
-0,29%
—1.466,801.464,701.467,191.458,36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,71%
2.380,40
-17,10
-0,71%
—2.397,502.395,032.412,012.370,64——
CRSP:NASDAQ
Crispr Therapeutics AG
US$53,58
+3,78%
(+1,95) 1D
US$52,57
-1,89% (-1,01)
After hours
Closed: 4 ພ.ພ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRSP...
Open
US$51,77
High
US$54,41
Low
US$51,77
Mkt. cap
໕,໑໗ ຕື້
Avg. vol.
໑,໖໘ ລ້ານ
Volume
໑,໗໑ ລ້ານ
52-wk high
US$78,48
52-wk low
US$33,03
EPS
US$-6,47
Beta
໑,໒໗
Shares outstanding
໙໖,໔໓ ລ້ານ
No. of employees
໓໙໓
News stories
From sources across the web
Profile
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland, Boston, Massachusetts, San Francisco, California and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023. Wikipedia
About Crispr Therapeutics AG
CEOSamarth Kulkarni
Employees393
Founded2013
HeadquartersZug, Zug, ສະວິດເຊີແລນ
SectorBiotechnology
Websitecrisprtx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ມ.ນ. 2025
ມິ.ຖ. 2025
ກ.ຍ. 2025
ທ.ວ. 2025
Revenue
865,00 ພັນ
892,00 ພັນ
889,00 ພັນ
864,00 ພັນ
Cost of goods sold
129,99 ລ້ານ
115,05 ລ້ານ
116,02 ລ້ານ
137,23 ລ້ານ
Cost of revenue
129,99 ລ້ານ
115,05 ລ້ານ
116,02 ລ້ານ
137,23 ລ້ານ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,30 ລ້ານ
18,92 ລ້ານ
16,93 ລ້ານ
18,40 ລ້ານ
Operating expense
19,30 ລ້ານ
18,92 ລ້ານ
16,93 ລ້ານ
18,40 ລ້ານ
Total operating expenses
149,29 ລ້ານ
133,96 ລ້ານ
132,95 ລ້ານ
155,63 ລ້ານ
Operating income
-148,42 ລ້ານ
-133,07 ລ້ານ
-132,06 ລ້ານ
-154,76 ລ້ານ
Other non operating income
13,54 ລ້ານ
22,07 ລ້ານ
26,24 ລ້ານ
24,76 ລ້ານ
EBT including unusual items
-134,89 ລ້ານ
-207,26 ລ້ານ
-105,82 ລ້ານ
-130,00 ລ້ານ
EBT excluding unusual items
-134,89 ລ້ານ
-111,00 ລ້ານ
-105,82 ລ້ານ
-130,00 ລ້ານ
Income tax expense
1,11 ລ້ານ
1,29 ລ້ານ
619,00 ພັນ
614,00 ພັນ
Effective tax rate
-0,82%
-0,62%
-0,58%
-0,47%
Other operating expenses
-
-
-
-
Net income
-136,00 ລ້ານ
-208,55 ລ້ານ
-106,44 ລ້ານ
-130,61 ລ້ານ
Net profit margin
-15.722,08%
-23.379,93%
-11.973,12%
-15.117,25%
Earnings per share
-1,58
-1,29
-1,17
-1,37
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-143,69 ລ້ານ
-128,42 ລ້ານ
-127,63 ລ້ານ
-149,10 ລ້ານ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer